About the cutaneous targets of bexarotene in CTCL patients

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Knol, Anne Chantal ^a   Quéreux, Gaëlle ^a,b   Brocard, Anabelle ^b   Ballanger, Fabienne ^b   Khammari, Amir ^a,b   Nguyen, Jean Michel ^c   Dréno, Brigitte ^a,b  

^a INSERM   (France)

^b CLINIQUE DERMATOLOGIQUE   (France)

^c CHU DE NANTES   (France)

Author keywords

Bexarotene; Cutaneous T cell lymphoma; Keratinocytes; Langerhans cells

Indexed keywords

BEXAROTENE; CD40 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; T6 ANTIGEN;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DRUG TARGETING; EXPLANT; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; LETTER; LYMPHOCYTE; MALE; SKIN BIOPSY;

AGED; ANTICARCINOGENIC AGENTS; ANTIGENS, CD1; APOPTOSIS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KERATINOCYTES; LANGERHANS CELLS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES; TETRAHYDRONAPHTHALENES;

EID: 77954849533     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00995.x     Document Type: Letter

References (30)

1. Olsen E, Vonderheid E, Pimpinelli N. Blood 2007, 110:1713-1722.
2. Hwang S T, Janik J E, Jaffe E S, Wilson W H. Lancet 2008, 371:945-957.
3. Stadler R, Otte H G, Luger T. Blood 1998, 92:3578-3581.
4. Thomsen K, Molin L, Volden G, Lange Wantzin G, Hellbe L. Acta Derm Venereol 1984, 64:563-566.
5. Thomsen K, Hammar H, Molin L, Volden G. Acta Derm Venereol 1989, 69:536-538.
6. Fitzpatrick J E, Mellette J R. J Dermatol Surg Oncol 1986, 12:626.
7. Kessler J F, Jones S E, Levine N, Lynch P J, Booth A R, Meyskens F L. Arch Dermatol 1987, 123:201-204.
8. Miller V A, Benedetti F M, Rigas J R. J Clin Oncol 1997, 15:790-795.
9. Prince H M, McCormack C, Ryan G. Australas J Dermatol 2001, 42:91-97.
10. Duvic M, Hymes K, Heald P. J Clin Oncol 2001, 19:2456-2471.
11. Duvic M, Martin A G, Kim Y. Arch Dermatol 2001, 137:581-593.
12. Zhang C, Hazarika P, Ni X, Weidner D A, Duvic M. Clin Cancer Res 2002, 8:1234-1240.
13. Cheng S X, Kupper T. Arch Dermatol 2001, 137:649-652.
14. Song J I, Lango M N, Hwang J D. Cancer Res 2001, 61:5919-5925.
15. Darro F, Cahen P, Vianna A. Breast Cancer Res Treat 1998, 51:39-55.
16. Matsuhashi S, Narisawa Y, Ozaki I, Mizuta T. Exp Dermatol 2007, 16:179-184.
17. Meunier L, Bohjanen K, Voorhees J J, Cooper K D. J Invest Dermatol 1994, 103:775-779.
18. Werner B, Bresch M, Brenner F M, Lima H C. J Cutan Pathol 2008, 35:302-310.
19. Carneiro R V, Sotto M N, Azevedo L S, Ianhez L E, Rivitti E A. Clin Transplant 2005, 19:115-121.
20. Gibson G E, O'Grady A, Kay E W, Leader M, Murphy G M. J Eur Acad Dermatol Venereol 1998, 10:130-136.
21. Dustin M L, Rothlein R, Bhan A K, Dinarello C A, Springer T A. J Immunol 1986, 137:245-254.
22. Shaw S, Luce G E. J Immunol 1987, 139:1037-1045.
23. Stade B G, Messer G, Riethmuller G, Johnson J P. Immunobiology 1990, 182:79-87.
24. Bouillon M, Tessier P, Boulianne R, Destrempe R, Audette M. Biochim Biophys Acta 1991, 1097:95-102.
25. Bassi V, Vitale M, Feliciello A, De Riu S, Rossi G, Fenzi G. J Clin Endocrinol Metab 1995, 80:1129-1135.
26. Wang Z, Cao Y, D'Urso C M, Ferrone S. Cancer Res 1992, 52:4766-4772.
27. Franssen M E, Smit J V, Van Erp P E, Van De Kerkhof P C. Br J Dermatol 2003, 149:506-512.
28. Smit J V, Franssen M E, de Jong E M. J Am Acad Dermatol 2004, 51:249-256.
29. Hoover L L, Burton E G, O'Neill M L. Biochim Biophys Acta 2008, 1783:2279-2286.
30. Hartmann T B, Mattern E, Wiedemann N. Exp Dermatol 2008, 17:324-334.